Wei Wu

Senior Director, Venture Investments, JJDC at Johnson & Johnson

Speaker

Wei is a Senior Director of Venture Investments at JJDC. She initiates and manages equity investments in biotech and medical device, to drive innovation and fuel new and sustainable businesses. Prior to joining JJDC, Wei was a Senior Associate at Illumina Ventures with a focus on genomics-enabled precision medicine including therapeutics, diagnostics, and life science tools. Prior to that, she was the Director of Healthcare Investment and Business Development of BOE technology group where she focused on VC fund investment, direct investment, and business development opportunities at the intersection of technology and life sciences. Wei was a Co-chair of the Biotech and Genomics Investment Committee of Life Science Angels that invest in seed-stage opportunities in the broad life science industry. Before becoming an investor, Wei was a R&D project lead at NuGEN Technologies (later acquired to become TECAN Genomics). 

Wei received her Ph.D. from UCLA in Biological Chemistry and completed her postdoctoral research in the Department of Pathology at Stanford University. She received a Bachelor of Science in Biological Sciences from Peking University, China. She published in top-tier journals including Cell, Nature, Neuron, Nature Review Genetics and served as a reviewer and editorial board member for numerous international biomedical journals. She was a Bronze Medalist of the 12th International Biology Olympiad.